ÂÜÀòÂÒÂ×

Aviola Mehmeti is a Business Development Associate at myNEO Therapeutics, focusing on pioneering breakthrough immunotherapies to fight cancer by tapping into novel tumor targets. Previously, Aviola worked as a Life Science Consultant at Fortress Biotech and conducted research at VIB on molecular regulators of CARD14 in psoriasis, production of nanobodies against RSV, and tissue expression patterns of TAOK3 in mice. Aviola holds a Master of Science degree in Biochemistry and Biotechnology from Ghent University and a Bachelor's degree in Biotechnology from the University of Tirana.